Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 60

Sort by

Sort Order Select

Journal Articles

Clinical analysis of central nervous system leukemia in patients with Acute Myeloid Leukemia

Hui Li, Xueping Luo, Junqing Wu, Chao Chen, He Huang, Weiyan Zheng

Blood (2025) 146 (Supplement 1): 5184.

https://doi.org/10.1182/blood-2025-5184

Published: 2025

Journal Articles

Disrupting monocytic AML and monocytic leukemia stem cells with a novel cladribine regimen: From bench to bedside

Jia Hu, Jingyi Huang, Wei Bian, Xiaoqing Zou, Yuanyuan Zhu, Weijia Huang, Yue Liang, Yi Zhao, Weiyan Zheng, Lixia Zhu, Xiu-Jin Ye, Yi Luo, Jimin Shi, Zhen Cai, He Huang, Shanshan Pei, Jie Sun

Blood (2025) 146 (Supplement 1): 1508.

https://doi.org/10.1182/blood-2025-1508

Published: 2025

Journal Articles

Low-dose 10-day decitabine plus venetoclax induced rapid MRD negativity and durable remission in de novo AML and high-risk MDS

Junqing Wu, Xueping Luo, Xiaoyu Liu, Jingwen Li, Shan Fu, He Huang, Weiyan Zheng

Blood (2025) 146 (Supplement 1): 3449.

https://doi.org/10.1182/blood-2025-3449

Published: 2025

Journal Articles

Cumulative burden of myelodysplasia-related gene mutations is associated with poor leukemia-free survival in ELN-2022 favorable-risk AML

Lulu Zhang, Shuangwei Ying, Fang Fang, Qian Li, Jingwen Li, Jie Sun, Weiyan Zheng, Zhimin Zhai, Yuanyuan Zhu

Blood (2025) 146 (Supplement 1): 7025.

https://doi.org/10.1182/blood-2025-7025

Published: 2025

Journal Articles

Genetic risk stratification in adults with AML receiving venetoclax-based intensive therapy: A real-world study

Yanmin Zhao, Yeqian Zhao, Shanshan Pei, Jimin Shi, Yi Luo, Jie Sun, Weiyan Zheng, Wenjun Wu, Yi Zhao, Lixia Zhu, Jian Yu, Lizhen Liu, Xiaoyu Lai, Huarui Fu, He Huang, Xiu-Jin Ye

Blood (2025) 146 (Supplement 1): 3404.

https://doi.org/10.1182/blood-2025-3404

Published: 2025

Journal Articles

Safety and activity of gene therapy with AAV8 GBA1 (LY-M001)on type I adults gaucher disease

Yishan Ye, Xueping Luo, Jingwen Li, Yixiong Chen, Qin Lin, He Huang, Weiyan Zheng

Blood (2025) 146 (Supplement 1): 6098.

https://doi.org/10.1182/blood-2025-6098

Published: 2025

Journal Articles

Reduced intensive chemotherapy combined with venetoclax in adult patients with Acute Myeloid Leukemia: A retrospective single-center analysis

Jingwen Li, Xueping Luo, Junqing Wu, He Huang, Weiyan Zheng

Blood (2025) 146 (Supplement 1): 6908.

https://doi.org/10.1182/blood-2025-6908

Published: 2025

Journal Articles

The Mutated of KRAS gene Determine the Fate of KMT2A-Rearranged AML Patients

Yibo Wu, Xiaolin Yuan, Xiaoyu Lai, Lizhen Liu, Jimin Shi, Weiyan Zheng, Jian Yu, Yanmin Zhao, Jie Sun, Xiujin Ye, Zhen Cai, He Huang, Shanshan Pei, Yi Luo

Blood (2024) 144 (Supplement 1): 843.

https://doi.org/10.1182/blood-2024-209592

Published: 2024

Journal Articles

Prognostic Risk Factors for Patients with Candida Tropicalis Fungemia Infections and Hematological Malignancies

Haisu Zhao, Shan Fu, Yuanyuan Zhu, He Huang, Weiyan Zheng

Blood (2023) 142 (Supplement 1): 5846.

https://doi.org/10.1182/blood-2023-189437

Published: 2023

Journal Articles

Reduced Intensity Condition of ATG Based Haploidentical Hematopoietic Stem Cell Transplantation in Elderly or Unfit Patients

Mingyue Pan, Yibo Wu, Luxin Yang, Jimin Shi, Xiaoyu Lai, Lizhen Liu, Yanmin Zhao, Jian Yu, Sun Jie, Weiyan Zheng, Wenjun Wu, Zhen Cai, He Huang, Yi Luo

Blood (2023) 142 (Supplement 1): 6977.

https://doi.org/10.1182/blood-2023-186211

Published: 2023

Journal Articles

Ultra-Low-Dose of Decitabine with Venetoclax As Induction and Consolidation Therapy for Elderly or Frail Newly Diagnosed Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome Patients

Weiyan Zheng, Shan Fu, Xuepin Luo, Yuanyuan Zhu, He Huang

Blood (2023) 142 (Supplement 1): 5934.

https://doi.org/10.1182/blood-2023-191155

Published: 2023

Journal Articles

Newly Dignosed Early T-Cell Precursor Acute Lymphoblastic Leukemia Successfully Treated with Venetoclax Combined with DA and IA Regime

Xuepin Luo, Shan Fu, Weiyan Zheng

Blood (2023) 142 (Supplement 1): 5888.

https://doi.org/10.1182/blood-2023-191324

Published: 2023

Journal Articles

IPSS-M Predicts Survival Outcomes Significantly Better Than IPSS-R in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasms

Blood (2023) 142 (Supplement 1): 3579.

https://doi.org/10.1182/blood-2023-189068

Published: 2023

Journal Articles

Low-Dose IA with Venetoclax Regimen As Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia

Weiyan Zheng

Blood (2023) 142 (Supplement 1): 5967.

https://doi.org/10.1182/blood-2023-186356

Published: 2023

Journal Articles

Clinical Characteristics Analysis of Gastrointestinal Peripheral T-Cell Lymphoma:Impact of Non-Emergency Surgery on Overall Survival

Jingsong He, Linlin Huang, Yang Yang, Yi Zhao, Xiu-Jin Ye, Weiyan Zheng, Sun Jie, Zhen Cai

Blood (2023) 142 (Supplement 1): 6214.

https://doi.org/10.1182/blood-2023-185509

Published: 2023

Journal Articles

A Single Center Retrospective Study on the Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Myeloid Neoplasms over 50 Years Old

Meng Liu, Xiaoli Wang, Yi Luo, Yanmin Zhao, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Weiyan Zheng, Jie Sun, Jingsong He, Yi Zhao, Guoqing Wei, Zhen Cai, He Huang, Jimin Shi

Blood (2023) 142 (Supplement 1): 7051.

https://doi.org/10.1182/blood-2023-184513

Published: 2023

Journal Articles

Biological and Therapeutic Implications of NPM1 -Mutated AML Receiving Allogeneic Hematopoietic Cell Transplantation

Xiaolin Yuan, Yibo Wu, Xiaoyu Lai, Luxin Yang, Jimin Shi, Lizhen Liu, Jian Yu, Yanmin Zhao, Weiyan Zheng, Wenjun Wu, Yi Zhao, Zhen Cai, He Huang, Yi Luo

Blood (2023) 142 (Supplement 1): 7037.

https://doi.org/10.1182/blood-2023-189289

Published: 2023

Journal Articles

Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma:Pathological Phenotype and Genetic Mutation Analysis of 12 Patients

Linlin Huang, Hanjin Yang, Yang Yang, Fang Yu, Yi Zhao, Xiujin Ye, Weiyan Zheng, Jie Sun, Enfan Zhang, Zhen Cai, Jingsong He

Blood (2023) 142 (Supplement 1): 4448.

https://doi.org/10.1182/blood-2023-186056

Published: 2023

Journal Articles

Hyperleukocytosis Does Not Present a Worse Prognosis in Acute Myeloid Leukemia (Non-APL) with Favorable Risk According to ELN-2022 Criteria: A Retrospective Study

Shuyue Bao, Jinya Lin, Yuanyuan Zhu, Weijia Huang, Weiyan Zheng, Guoqing Wei, Zhen Cai, Yi Luo, Yi Zhao, Jimin Shi, He Huang, Jie Sun

Blood (2023) 142 (Supplement 1): 5867.

https://doi.org/10.1182/blood-2023-186943

Published: 2023

Journal Articles

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors

Bingqian Jiang, Yanmin Zhao, Yi Luo, Jian Yu, Yi Chen, Baodong Ye, Huarui Fu, Xiaoyu Lai, Lizhen Liu, Yishan Ye, Weiyan Zheng, Jie Sun, Jingsong He, Yi Zhao, Guoqing Wei, Zhen Cai, He Huang, Jimin Shi

Blood (2023) 142 (Supplement 1): 2243.

https://doi.org/10.1182/blood-2023-182809

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Clinical analysis of central nervous system leukemia in patients with Acute Myeloid Leukemia

Disrupting monocytic AML and monocytic leukemia stem cells with a novel cladribine regimen: From bench to bedside

Low-dose 10-day decitabine plus venetoclax induced rapid MRD negativity and durable remission in de novo AML and high-risk MDS

Cumulative burden of myelodysplasia-related gene mutations is associated with poor leukemia-free survival in ELN-2022 favorable-risk AML

Genetic risk stratification in adults with AML receiving venetoclax-based intensive therapy: A real-world study

Safety and activity of gene therapy with AAV8 GBA1 (LY-M001)on type I adults gaucher disease

Reduced intensive chemotherapy combined with venetoclax in adult patients with Acute Myeloid Leukemia: A retrospective single-center analysis

The Mutated of KRAS gene Determine the Fate of KMT2A-Rearranged AML Patients

Prognostic Risk Factors for Patients with Candida Tropicalis Fungemia Infections and Hematological Malignancies

Reduced Intensity Condition of ATG Based Haploidentical Hematopoietic Stem Cell Transplantation in Elderly or Unfit Patients

Ultra-Low-Dose of Decitabine with Venetoclax As Induction and Consolidation Therapy for Elderly or Frail Newly Diagnosed Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome Patients

Newly Dignosed Early T-Cell Precursor Acute Lymphoblastic Leukemia Successfully Treated with Venetoclax Combined with DA and IA Regime

IPSS-M Predicts Survival Outcomes Significantly Better Than IPSS-R in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasms

Low-Dose IA with Venetoclax Regimen As Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia

Clinical Characteristics Analysis of Gastrointestinal Peripheral T-Cell Lymphoma:Impact of Non-Emergency Surgery on Overall Survival

A Single Center Retrospective Study on the Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Myeloid Neoplasms over 50 Years Old

Biological and Therapeutic Implications of NPM1 -Mutated AML Receiving Allogeneic Hematopoietic Cell Transplantation

Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma:Pathological Phenotype and Genetic Mutation Analysis of 12 Patients

Hyperleukocytosis Does Not Present a Worse Prognosis in Acute Myeloid Leukemia (Non-APL) with Favorable Risk According to ELN-2022 Criteria: A Retrospective Study

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only